6101 - 6125 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Association Between Pathology and Electroencephalographic Activity in Parkinson’s DiseaseJournal Name: Clinical EEG and NeurosciencePublisher: SAGE PublicationsVol: 49Issue #: 5Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1550059417696179Citation Count: 10
-
OPENTitle: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0007-3Best OA location URL: https://www.nature.com/articles/s41531-017-0007-3.pdfCitation Count: 29
-
OPENTitle: Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 98Issue #:Start Page: 122End Page: 136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.11.004Best OA location URL: https://europepmc.org/articles/pmc5718210?pdf=renderCitation Count: 11
- Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons2017OPENTitle: Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic AxonsJournal Name: NeuronPublisher: Elsevier BVVol: 93Issue #: 4Start Page: 882End Page: 896.e5Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.01.019Best OA location URL: http://www.cell.com/article/S0896627317300430/pdfCitation Count: 170
-
OPENTitle: Regional volumetric change in Parkinson's disease with cognitive declineJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 373Issue #:Start Page: 88End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030Best OA location URL: http://manuscript.elsevier.com/S0022510X16308231/pdf/S0022510X16308231.pdfCitation Count: 26
- Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies2017RESTRICTEDTitle: Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studiesJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 2Start Page: 171End Page: 180Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24859Best OA location URL: https://kclpure.kcl.ac.uk/portal/files/62952075/Serontin_Transporter_in_Parkinson_s_disease_SERT_Accepted_GREEN_AAM.pdfCitation Count: 79
- The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease2017OPENTitle: The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 39Issue #:Start Page: 31End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.01.015Best OA location URL: https://europepmc.org/articles/pmc5441947?pdf=renderCitation Count: 45
- The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism2017OPENTitle: The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and MetabolismJournal Name: Cell ReportsPublisher: Elsevier BVVol: 18Issue #: 6Start Page: 1458End Page: 1472Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.01.029Best OA location URL: http://www.cell.com/article/S2211124717300669/pdfCitation Count: 71
-
OPENTitle: Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 10Start Page: 2735End Page: 2740Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1621218114Best OA location URL: https://www.pnas.org/content/pnas/114/10/2735.full.pdfCitation Count: 32
- Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing2017OPENTitle: Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencingJournal Name: Genome BiologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13059-017-1147-9Best OA location URL: https://genomebiology.biomedcentral.com/track/pdf/10.1186/s13059-017-1147-9Citation Count: 106
-
OPENTitle: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic HypotensionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 298End Page: 308Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12478Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12478Citation Count: 66
- The human subthalamic nucleus and globus pallidus internus differentially encode reward during action control2017OPENTitle: The human subthalamic nucleus and globus pallidus internus differentially encode reward during action controlJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 4Start Page: 1952End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23496Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23496Citation Count: 30
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease2017RESTRICTEDTitle: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 291Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012Citation Count: 20
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 16
-
OPENTitle: Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na+/K+ ATPase Activity in Dendritic CellsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep41117Best OA location URL: https://www.nature.com/articles/srep41117.pdfCitation Count: 8
-
RESTRICTEDTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 216
-
OPENTitle: An early and late peak in microglial activation in Alzheimer’s disease trajectoryJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: aww349End Page: aww349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww349Best OA location URL: https://academic.oup.com/brain/article-pdf/140/3/792/24174911/aww349.pdfCitation Count: 330
-
RESTRICTEDTitle: Essential pitfalls in “essential” tremorJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 325End Page: 331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26919Best OA location URL: https://europepmc.org/articles/pmc5359065?pdf=renderCitation Count: 77
-
OPENTitle: Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 143End Page: 147Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160985Best OA location URL: https://europepmc.org/articles/pmc5470115?pdf=renderCitation Count: 8
-
OPENTitle: The Identification of Alpha-Synuclein as the First Parkinson Disease GeneJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 7Issue #: s1Start Page: S43End Page: S49Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-179003Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd179003?id=journal-of-parkinsons-disease%2Fjpd179003Citation Count: 66
-
RESTRICTEDTitle: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 2Start Page: 427End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13223Citation Count: 53
- Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling2017OPENTitle: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signalingJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0153-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0153-4Citation Count: 47
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation2017OPENTitle: The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep DeprivationJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 11Start Page: 2196End Page: 2205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2017.13Best OA location URL: https://www.nature.com/articles/npp201713.pdfCitation Count: 28
-
RESTRICTEDTitle: Multicellular hypothesis for the pathogenesis of Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: 5Start Page: 1792End Page: 1795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.201601221rCitation Count: 19
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 4